Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Prahran

Novartis Investigative Site, Adelaide

Memorial Sloan Kettering Cancer Center MSKCC, New York

Lancaster Cancer Center, Lancaster

Duke University Medical Center Dept. of DUMC (4), Durham

Cancer Centers of the Carolinas Dept. of CC of the Carolinas, Greenville

Novartis Investigative Site, Altunizade

Novartis Investigative Site, Izmir

University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst., Mobile

University of Tennessee Cancer Institute SC-2, Memphis

Novartis Investigative Site, Nantes

Novartis Investigative Site, Bochum

Novartis Investigative Site, Cologne

Medical College of Wisconsin Med College of Wisconsin, Milwaukee

University of Wisconsin SC, Madison

Mayo Clinic - Rochester Rochester, Rochester

Novartis Investigative Site, Heidelberg

Hematology and Oncology Specialists Dept of Hem&Onc Specialist - 2, Metairie

Kootenai Medical Center Kootenai Medical Center, Coeur d'Alene

Central Hematology Oncology Medical Group, Alhambra

St. Jude Heritage Medical Group Virginia Crosson Cancer Center, Yorba Linda

Central Coast Medical Oncology Corporation, Santa Maria

University of Texas Southwestern Medical Center UTSW Medical Center, Dallas

Novartis Investigative Site, Toronto

Novartis Investigative Site, Montreal

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Ankara